** Shares of telehealth firm Doximity DOCS.N rise 24.4% to $72.50 premarket
** On Thursday, co forecast fiscal 2025 rev. to be between $564.6 mln and $565.6 mln, up from its previous range of $535 mln to $540 mln; analysts estimate 2025 rev. to be $554.3 mln - LSEG-compiled data
** Co forecasts Q4 rev. to be between $132.5 mln and $133.5 mln, above analysts' est of $129.2 mln
** Co reported Q3 adj. profit of 45 cents/shr vs analysts' est. of 34 cents/shr
** Co posted Q3 revenue of $168.6 mln vs estimates of $152.8 mln
** At least six brokerages raised PT on DOCS post results
** DOCS gained ~87% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.